Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07632157
PHASE3

MAGNEsium With meToprolol for Rate Control In Atrial Fibrillation

Sponsor: Wake Forest University Health Sciences

View on ClinicalTrials.gov

Summary

The purpose of this research study is to find out if the use of magnesium in addition to Metoprolol, a rate controlling medication that you would be offered in the Emergency Department today unrelated to this study, will help reduce your high heart rate (rapid ventricular response).

Official title: MAGNEsium With meToprolol for Rate Control In Atrial Fibrillation (MAGNETIC-AF)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

196

Start Date

2026-06

Completion Date

2028-12

Last Updated

2026-06-08

Healthy Volunteers

No

Interventions

DRUG

Magnesium Sulfate 2g

Magnesium Sulfate 2g for the treatment of atrial fibrillation or atrial flutter with rapid ventricular response (AFF RVR)

DRUG

Magnesium Sulfate 4g

Magnesium Sulfate 4g for the treatment of atrial fibrillation or atrial flutter with rapid ventricular response (AFF RVR)

DRUG

Saline (0.9% NaCl)

The control group will receive a bolus of normal saline of the same volume and infused over 15 minutes.

Locations (1)

Advocate Christ Medical Center Emergency Department (ACMC ED)

Oak Lawn, Illinois, United States